Chromophobe renal cell carcinoma with prolonged response to targeted therapy: a case report
Open Access
- 23 April 2012
- journal article
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 6 (1) , 115
Abstract
Chromophobe renal cell carcinoma is universally accepted as a distinct subtype of renal cell carcinoma. There are conflicting reports on prognosis, and few data on response to treatment exist. Currently, we do not have any effective treatment for the metastatic disease apart from surgical procedures. Current strategies are based on results obtained in the context of clear cell-type renal cell carcinoma. Separate trials for rare histologies seem unfeasible and are unlikely to be performed. For these cases, clinical observations are an important part for advancing therapeutic insight. In recent years, novel tyrosine kinase inhibitors have been shown to have significant clinical benefit in advanced renal cell carcinoma.Keywords
This publication has 13 references indexed in Scilit:
- Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trialThe Lancet Oncology, 2009
- Immunohistochemical Analysis for Cytokeratin 7, KIT, and PAX2American Journal of Clinical Pathology, 2007
- Sunitinib versus Interferon Alfa in Metastatic Renal-Cell CarcinomaNew England Journal of Medicine, 2007
- Sorafenib in Advanced Clear-Cell Renal-Cell CarcinomaNew England Journal of Medicine, 2007
- Treatment outcome for metastatic papillary renal cell carcinoma patientsCancer, 2006
- Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter ExperienceJournal of Clinical Oncology, 2005
- Chromophobe renal cell carcinoma: Comprehensive analysis of 104 cases from multicenter European databaseUrology, 2005
- Expression of vascular endothelial growth factor protein in human renal cell carcinomaBJU International, 2004
- Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinomaAnnals of Surgical Oncology, 2004
- Treatment Outcome and Survival Associated With Metastatic Renal Cell Carcinoma of Non–Clear-Cell HistologyJournal of Clinical Oncology, 2002